⚡ This site contains affiliate links. We may earn a commission if you purchase through our links — at no cost to you.
Top view of green filled syringes and measuring tape on a white background, emphasizing healthcare themes.

Semaglutide vs Victoza (Liraglutide): Which Is Better? (2026)

Medically Reviewed Content

Written by Rob Anderson, Health Technology Researcher & Medical Content Specialist. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any medication.

Quick verdict: Semaglutide (Ozempic/Wegovy) has largely superseded liraglutide (Victoza/Saxenda) for both diabetes and weight management. It produces roughly twice the weight loss, requires only weekly instead of daily injection, and has stronger cardiovascular evidence. Liraglutide remains an alternative for people who respond poorly to semaglutide.

Liraglutide was the GLP-1 standard-bearer before semaglutide arrived. Understanding how they compare helps people who are on liraglutide now, or considering switching.

The Key Differences

Factor Semaglutide Liraglutide
Brand names Ozempic, Wegovy Victoza, Saxenda
Dosing frequency Weekly injection Daily injection
Weight loss (max dose) ~15% body weight ~5–8% body weight
CV benefit proven ✅ Strong evidence ✅ LEADER trial
Compounded available ✅ From $149/mo Very limited
HbA1c reduction 1.4–1.8% 1.0–1.5%

Why Most Physicians Now Prefer Semaglutide

The combination of weekly dosing (far easier compliance), significantly greater weight loss, and at least comparable cardiovascular data has made semaglutide the first-choice GLP-1 agonist for most clinical situations. When the STEP trials showed semaglutide producing twice the weight loss of the liraglutide comparator arm in direct head-to-head data, the preference shifted substantially.

When Liraglutide Might Still Be Chosen

Some patients who experience severe nausea on semaglutide tolerate liraglutide better, possibly because the daily dosing allows the body to maintain steadier (rather than peak-and-trough) drug levels. For patients with specific clinical histories or those in regions where semaglutide availability is limited, liraglutide remains a valid GLP-1 option.

Cost Comparison: Semaglutide vs Liraglutide in 2026

Cost is often the deciding factor when choosing between semaglutide and liraglutide. Brand-name Ozempic (semaglutide) lists at approximately $900-$1,000 per month without insurance, while Saxenda (liraglutide for weight loss) costs around $1,300-$1,500 per month. Victoza (liraglutide for diabetes) is priced similarly to Ozempic.

However, compounded semaglutide has changed the equation dramatically. Compounded versions are available through telehealth providers for $150-$450 per month, making semaglutide significantly more affordable than brand liraglutide. There is currently no widely available compounded liraglutide option.

Insurance coverage also differs. Many insurers cover Ozempic for type 2 diabetes but not for weight loss alone. Saxenda has broader weight loss coverage from some insurers, but prior authorization requirements can delay access. Check with your provider about GLP-1 insurance coverage options before making a decision.

Side Effect Comparison

Both medications share similar gastrointestinal side effects since they target the same GLP-1 receptor pathway. Nausea, vomiting, diarrhea, and constipation are the most commonly reported issues with both drugs. However, the frequency and severity can differ due to their pharmacokinetic profiles.

Semaglutide’s longer half-life (approximately 7 days vs 13 hours for liraglutide) means side effects may be more sustained but are typically managed through slower dose titration. Liraglutide’s daily dosing allows for more gradual adjustment, which some patients find easier to tolerate during the initial weeks.

Serious side effects are rare with both medications but include pancreatitis, gallbladder problems, and potential thyroid concerns. Both carry the same FDA boxed warning about thyroid C-cell tumors observed in animal studies. Long-term safety data is more extensive for liraglutide, as it has been on the market since 2010, compared to semaglutide’s 2017 approval.

Dosing and Convenience

One of semaglutide’s biggest practical advantages is its once-weekly dosing schedule. Patients inject semaglutide just once per week using a pre-filled pen, which many find easier to remember and less burdensome than daily injections.

Liraglutide requires daily subcutaneous injections, which means 365 injections per year compared to semaglutide’s 52. For patients who dislike needles or have busy schedules, this convenience difference is significant. Some patients also report that the weekly injection feels more manageable psychologically than a daily medical routine.

For those who prefer to avoid injections entirely, semaglutide is available in an oral form called Rybelsus. There is no oral formulation of liraglutide currently available, giving semaglutide another advantage in terms of administration flexibility.

Frequently Asked Questions

Q: Is semaglutide better than liraglutide?

A: For weight loss, semaglutide (Wegovy 2.4mg) produces significantly more weight loss — approximately 15% of body weight vs 5–8% for liraglutide (Saxenda 3mg). Semaglutide also has a more convenient once-weekly injection compared to liraglutide’s daily injection. Most prescribers now prefer semaglutide for weight management.

Q: Can you switch from Victoza to Ozempic?

A: Yes, with physician guidance. The transition from liraglutide (Victoza) to semaglutide (Ozempic) is a common switch for people with T2D who want better glucose control or weight loss outcomes. Your doctor will advise on appropriate starting dose and timing.

Q: Which has fewer side effects — semaglutide or liraglutide?

A: Both share similar GI-dominated side effects (nausea, vomiting, diarrhoea). Overall tolerability is broadly comparable. Some patients who cannot tolerate semaglutide find liraglutide more manageable, and vice versa. Individual response varies.

Start With the Most Effective GLP-1 Available

Physician-supervised compounded semaglutide from $149/month. No insurance required.

Check My Eligibility Free →

Sponsored | Affiliate link

Affiliate disclosure: This article contains affiliate links. See our Affiliate Disclosure.

Sources & References

This content is regularly reviewed and updated to reflect the latest medical research and FDA guidance.

💊 Check Eligibility for Compounded Semaglutide →